1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow 1018 oligonucleotide: new trials by email Literature Review of 1018 oligonucleotide trials Research Report on 1018 oligonucleotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma Rituxan, 1018 ISS - Non-Hodgkin's Lymphoma | Phase 2 | Completed | Dana-Farber Cancer Institute | 30 | 2004-07-01 | 2010-01-29 |
Dana-Farber Cancer Institute (1)
United States (1)